Teva loses key battle in Copaxone patent fight - Israel News, Ynetnews
 
ynetnews
web


   Israel News

Israel News
World News
Israel Opinion
Jewish
Israel Business
Israel Culture
Israel Travel
Breaking News

 

Teva loses key battle in Copaxone patent fight

Published: 04.19.14, 08:25 / Israel News

US Supreme Court Chief Justice John Roberts on Friday denied a request by Teva Pharmaceutical Industries Ltd to stay a lower-court ruling in a patent case that favored the developers of generic versions of Teva's top-selling multiple sclerosis drug.

 

The decision could help pave the way for generic competitors of the Israeli pharmaceutical company's Copaxone drug to go on the market as soon as May 2014. (Reuters)

 

  PrintPrint  Send to friendSend to friend   
Tag with Del.icio.us Bookmark to del.icio.us




 

RSS RSS | About | Contact Us | Privacy Policy | Terms of use | Advertise with us | Site Map

Site developed by  YIT Advanced Technology Solutions

 
פיקוד העורף התרעה במרחב:
    רשימת יישובים במרחב